Block 4 Flashcards
Methotrexate
Antimetabolite (Chemotherapy)
- folate analog, binds to dihydrofolate reductase (DHFR) resulting in inhibition of tetrahydrofolate (THF)
- converted to a series of polyglutamates for therapeutic action
- NEPHROTOXICITY
- treats breast cancer, RA, psoriasis
Leucovorin
Methotrexate rescue
Cyclophosphamide
Alkylating Agent (Chemotherapy)
- alkylates N7 position of guanine twice, creating a cross link, inhibits DNA synth
- must be activated by cytochrome P450
- metabolite acrolein causes severe cystitis
- treats breast cancer, RA, MS
Mesna
Cyclophosphamide rescue
Cisplatin
Alkylating Agent (Chemotherapy)
- alkylates N7 position of guanine twice, creating a cross link, inhibits DNA synth
- kills tumor cells at all stages
- PT MUST BE GIVEN SALINE SOLUTION BEFORE, DURING, AND AFTER ADMIN TO AVOID NEPHROTOXICITY
- treats solid tumors
Doxorubicin (Hydroxydaunorubicin)
Cytotoxic Antibiotic (Chemotherapy)
- Inhibit Topoisomerase II
- High affinity DNA binding through INTERCALATION, blocks DNA/RNA synth
- Free radical generation
- Bind cellular membranes to alter fluidity and ion transport
- urine may turn bright red
- can cause cardiotoxicity
- treats breast cancer
Vincristine (Oncovin)
Microtubule Inhibitor (Chemotherapy)
- disrupts microtubule assembly and causes mitotic arrest in M phase –> cell death
- metabolized by cytochrome P450
- Nephrotoxicity with neuropathy
- BLISTERS (vesicant)
- treats acute lymphoblastic leukemia
- derived from periwinkle plant
Paclitaxel
Microtubule Inhibitor (Chemotherapy)
- binds microtubules with enhanced tubular polymerization causing mitotic arrest
- metabolized by cytochrome P450
- peripheral neuropathy, hypersensitivity, myalgia, arthralgia, HAND-FOOT SYNDROME
- treats solid tumors and breast cancer
- derived from yew plant
Imatinib
Protein Kinase Inhibitor (Chemotherapy)
- TARGETED THERAPY
- inhibits Bcr-Abl Tyrosine Kinase and other receptor kinases, prevents kinase phosphorylation
- CYP3A4 metabolism
- fluid retention with ankle and periorbital edema
- treats Philadelphia chromosome, chronic leukemia, GI stromal tumor
Trastuzumab
HER2/neu Receptor Antibodies (Chemotherapy)
- IMMUNOTHERAPY/TARGETED THERAPY
- monoclonal antibody interfering with HER2/neu receptor which inhibits epidermal growth factor (HER2 expressed 100x more in cancer cells)
- binds to domain IV of extracellular segment of HER2 and arrests cells in G1 phase
- causes cardiac dysfunction
- treats HER2-positive breast cancer
Prednisone
Glucocorticoid Receptor Agonist (Chemotherapy)
- inhibit leukocyte infiltration
- interfere with inflammatory response mediators
- suppresses immune response
- reduce edema and scar tissue
- must be converted to prednisolone in liver to become activated
- causes Cushing like symptoms
- treats acute lymphoblastic leukemia, UC, Crohns
CHOP Therapy
- Cyclophosphamide
- Doxorubicin (Hydroxydaunorubicin)
- Vincristine (Oncovin)
- Prednisone
treats non-Hodgkin lymphoma
Misoprostol
Gastric Acid Suppressant / Mucosal Lining Protectant
- Prostaglandin analog
- binds to EP3 receptors on parietal cells to inhibit cAMP and H-K ATPase acid secretion
- binds to EP3 to increase mucin and bicarbonate secretion from epithelial cells
- extensive first pass metabolism to principle metabolite misoprostol acid
- high incidence of adverse effects: diarrhea, IBD exacerbation, INDUCES ABORTION
- can protect from NSAID mucosal injury
Omeprazole
PPI
- Inhibits H-K ATPase, prevents acid production
- promotes healing for gastric ulcer, GERD
- require multiple doses for full effect
- subject to CYP3A4 metabolism, inhibits CYP2C19
- inhibits Cytochrome P450 and increases other drugs half lives
- can cause acid rebound if discontinued
Pantoprazole
PPI
- Inhibits H-K ATPase, prevents acid production
- promotes healing for gastric ulcer, GERD
- require multiple doses for full effect
- subject to CYP3A4 and CYP2C19 metabolism
- inhibits Cytochrome P450 and increases other drugs half lives
- can cause acid rebound if discontinued
Cimetidine
H2 Antagonist
- reversibly binds H2 receptors, inhibits H2 activation of cAMP and the activation of H-K ATPase
- most effective against nocturnal secretion
- cause gynecomastia and impotence in males
- CAN DEVELOP TOLERANCE
- displaces dihydrotestosterone from binding sites and inhibits P450 metabolism of estrogen, other drugs
- can cause acid rebound if discontinued
Famotidine
H2 Antagonist
- reversibly binds H2 receptors, inhibits H2 activation of cAMP and the activation of H-K ATPase
- most effective against nocturnal secretion
- cause gynecomastia and impotence in males
- CAN DEVELOP TOLERANCE
- virtually no drug interactions
- can cause acid rebound if discontinued
Sucralfate
Mucosal Lining Protectant
- made of aluminum hydroxide
- cross links in pH <4 to create a viscous, sticky polymer to coat the stomach lining
- causes constipation
- used when limited response to PPI or with ulcers
Sodium Bicarbonate
Antacid
- neutralize acid, don’t block secretion
- increases pH from 1 to 3.5, short action
- decreases absorption of other drugs
- causes alkalosis with excessive use
- PRODUCES CO2 GAS
Calcium Carbonate
Antacid
- neutralize acid, don’t block secretion
- increases pH from 1 to 3.5, short action
- decreases absorption of other drugs
- causes systemic alkalosis with excessive use
- PRODUCES CO2 GAS, causes constipation, acid rebound
- LONG ACTING
Magnesium Hydroxide
Antacid
- neutralize acid, don’t block secretion
- increases pH from 1 to 3.5, short action
- decreases absorption of other drugs
- causes diarrhea
- increases plasma magnesium and can lead to CNS toxicity
Aluminum Hydroxide
Antacid
- neutralize acid, don’t block secretion
- increases pH from 1 to 3.5, short action
- decreases absorption of other drugs
- causes constipation, nephrotoxicity, myopathy
- REDUCES PHOSPHATE REABSORPTION –> removes calcium from bone and weakens it
Magnesium-Aluminum Combo
Antacid
- neutralize acid, don’t block secretion
- increases pH from 1 to 3.5, short action
- decreases absorption of other drugs
- DOES NOT CAUSE CONSTIPATION OR DIARRHEA
- exposed to 2 cations, problem if renal function is decreased
H. Pylori treatment options
A: x 7 days
1. PPI or H2 antagonist
2. Amoxicillin
3. Clarithromycin or Metronidazole
B: x 7 days
1. PPI
2. Tetracycline
3. Bismuth
4. Metronidazole
Domperidone
Prokinetic - enhance GI motility
- Dopamine antagonist, enhances Ach release
- inhibit emesis via CTZ (chemoreceptor trigger zone)
- no extrapyramidal effects, but can increase prolactin release
Metoclopramide
Prokinetic AND Antiemetic
- Dopamine antagonist
- doesn’t affect lower GI motility
- also a 5-HT3 antagonist/5-HT4 agonist (increase ACh)
- extrapyramidal effects –> tardive dyskinesia
Dicyclomine
Antispasmodic - enhance GI motility
- block M2 cholinergic receptor in enteric plexus to inhibit motility
- limited side effects at low dose
- high doses cause dry mouth, visual disturbance, constipation, urinary retention
Hycosamine
Antispasmodic - inhibit GI motility
- block M2 cholinergic receptor in enteric plexus to inhibit motility
- limited side effects at low dose
- high doses cause dry mouth, visual disturbance, constipation, urinary retention
Meclizine
Antiemetic - Antihistamine (H1R Antagonist)
- depress labyrinth excitability in ear
- can cause CNS depression
- good for motion sickness
Doxylamine (+ pyridoxine)
Antiemetic - Antihistamine (H1R Antagonist)
- depress labyrinth excitability in ear
- can cause CNS depression
- good for motion sickness
Diphenhydramine
Antiemetic - Antihistamine (H1R Antagonist)
- depress labyrinth excitability in ear
- can cause CNS depression
- good for motion sickness
Promethazine
Antiemetic - Antihistamine (H1R Antagonist)
- ALSO BLOCKS D2 RECEPTORS
- depress labyrinth excitability in ear
- can cause CNS depression
- good for motion sickness